Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study

SIMPLE SUMMARY: Despite a significant improvement in clinical outcomes and the emergence of novel and potentially curative strategies, a noticeable number of oncological patients witness a disease relapse after surgery. Adjuvant treatments have been developed to reduce the risk of recurrence and gai...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessandro, Mollica, Veronica, Marchetti, Andrea, Nuvola, Giacomo, Rosellini, Matteo, Tassinari, Elisa, Molina-Cerrillo, Javier, Myint, Zin W., Buchler, Tomas, Monteiro, Fernando Sabino Marques, Grande, Enrique, Santoni, Matteo, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455029/
https://www.ncbi.nlm.nih.gov/pubmed/36077679
http://dx.doi.org/10.3390/cancers14174142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455029/
https://www.ncbi.nlm.nih.gov/pubmed/36077679
http://dx.doi.org/10.3390/cancers14174142

Ejemplares similares